Pharmaceutical consultation as a tool to improve health outcomes for patients with type 2 diabetes

This study develops and evaluates a pharmaceutical consultation program (PCP) to improve treatment for Type 2 diabetes patients (T2DP) and reduce risk factors for diabetic complications with possible application in other chronic diseases. We recruited T2DP receiving conventional medical treatment bu...

Description complète

Détails bibliographiques
Auteurs principaux: Arnaldo Zubioli, Maria Angélica Rafaini Covas Pereira da Silva, Raquel Soares Tasca, Rui Curi, Roberto Barbosa Bazotte
Format: Article
Langue:English
Publié: Universidade de São Paulo 2013-03-01
Collection:Brazilian Journal of Pharmaceutical Sciences
Sujets:
Accès en ligne:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000100010